Background: Across the globe, upper respiratory tract infections (URTIs) are the most prevalent cause of morbidity in childhood. Aims: The aim of our study is to analyze the incidence and etiology of bacterial URTIs in Bulgarian children, as well as the increasing antimicrobial resistance to the most common etiologic agents over a period of 17 years. Study Design: Retrospective study.
Globally, respiratory infections represent the most common cause of morbidity in children and often require antimicrobial therapy (1, 2) The typical onset is like a banal viral infection, but on the contrary from the adult patients where the infections are often self-limiting and rarely cause any complication, Upper respiratory tract infections (URTIs) in childhood have a specific characteristics -they frequently are with combined microbial etiology, with prolonged courses and quickly evolve into lung inflammatory complications. This secondary infection is usually a bacterial one originating from the conditionally pathogenic microorganisms composing the normal colonizing flora of nasopharynx (1) (2) (3) (4) (5) .
The rapid development of bacterial resistance in recent years to the most popular antimicrobial agents has affected the etiology of respiratory infections, as well as recommendations regarding the initial approach to therapy (6) (7) (8) (9) (10) .
The aim of our study is to analyze the etiology and incidence of bacterial URTIs in Bulgarian children as well as the increasing antimicrobial resistance to the most common antibiotic agents for a period from 1998 to 2014.
MATERIALS AND METHODS

Patients
The study material comprised the data from 4768 patients. The inclusion criteria that were met by all patients were: children with a clinical manifestation respiratory infection aged from 1 to 16 years; consulted with a certified pediatrician and an otorhinolaryngologist to prove the presence of least one of the following disease entities: rhinosinusitis, ethmoiditis, nasopharyngitis, pharyngotonsillitis, adenoiditis; without previous antimicrobial treatment for at least 7 days before microbiological testing. The tests were performed after obtaining a signed informed consent of the legal guardian. The patients with lower airways or lung involvement or with sepsis were excluded. There was no personal patient information in the database. The Hospital's Ethics Committee granted study approval. The therapy prescribed was as all the clinical practice and guidelines approved, according the current pathogen.
Clinical material and methods
For the analyzed period, we examined the following samples: from patients with rhinopharyngitis, tonsillopharyngitis, and adenoiditis: nasopharyngeal swab (n=2848); from patients with rhinosinusitis, ethmoiditis and rhinopharyngitis: nasal swab (n=1625) or puncture liquid from sinus (n=105). All samples were obtained before the first administration of antimicrobial therapy. A special procedure is used for obtaining of samples in children with epiglottitis (250) -the tongue is stretched far forward and thus the larynx rises up and the epiglottis opens. A sterile aspiration drain pad or swab is then taken for examination. All the samples were obtained by a specialist from the affected area and then sent to the laboratory in the corresponding transport medium.
The standard protocol for microbiological diagnostic follow-up and tests was followed in the laboratory. For isolation and detection of the rigorous etiologic bacterial agents we used routine nutrition media such as Blood agar base supplemented with 5% sheep blood, MacConkey agar, Candida chrome agar and developed and implemented by our team selective media chocolate agar with vancomycin for moraxellae and haemophilae, for their identification, as well as a quantitative method for correct evaluation of the clinical significance of isolates (3) . The cultivation of inoculated samples on different media was performed in aerobic and in microaerophilic atmosphere respectively for various pathogens (3, 7) . For identification of the isolated clinical strains we used mainly the products and systems by Crystal BD BBL (BBL; Becton, Dickinson, Germany) and RapID System Remel Thermo Fisher Scientific (Remel, Thermo Fisher Scientific Remel Products; Santa Fe, USA). All bacterial isolates from the symptomatic children, before treatment, in a microbial number over the critical one for an infectious process (>100 000 CFU/mL), were considered as significant (3) . The other indicative tests for bacterial infection such as C-reactive protein (CRP) and leukocytosis with granulocytosis (more than 77%) in manual screens of differential blood smears had been positive as well. For CRP detection (positive test 6 mg/L or higher) was used serums collected by standard procedures and slide agglutination test C-Reactive protein (CRP) latex (BioSystems S.A.; Costa Brava, Barcelona, Spain).
Susceptibilities to investigated pathogens were determined by Kirby-Bauer disk-diffusion method. Due to the necessity for some peculiar cases and for a representative sample strain, minimal inhibitory concentration (MIC) according the criteria of CLSI were measured (7, 11) . ß-lactamase production in staphylococci, moraxellae and haemophilae was detected with Cefinase disc BD BBL, and by using polymerase chain reaction (PCR) ß-lactam resistance genes were probed (7, 8, 12) . According the results from in vitro test for antimicrobial susceptibility recommendation for treatment was given and some conclusions for a correct empiric therapy were established.
Statistical analysis
The data were analyzed using Chi-square and Fisher's exact test for categorical variables. All analytical procedures were performed using Statistical Package for the Social Sciences (SPSS) for Windows, Version 16.0. (SPSS Inc.; Chicago, IL, USA). We considered p values of ≤0.05 to indicate statistical significance.
RESULTS
In 77% of cases, a specific bacterial etiology was confirmed. The bacterial spectrum of the URTI causes in children with different clinical entities is presented in Figure 1 . cus pyogenes (S. pyogenes) with H. influenzae (3.49%) ( Figure 1 ). As is obvious from the figure, each disease has a unique etiologic profile. Statistically significant differences are found between etiology of epiglottitis and tonsillopharyngitis (p=0.001); epiglottitis and rhinopharyngitis (p=0.004); epiglottitis and rhinosinusitis (p=0.012); tonsillopharyngitis and ethmoiditis (p=0.000); tonsillopharyngitis and adenoiditis (p=0.023); adenoiditis and ethmoiditis (p=0.011); tonsillopharyngitis and rhinosinusitis (p=0.000); adenoiditis and rhinosinusitis (p=0.000); ethmoiditis and rhinopharyngitis (p=0.000); rhinosinusitis and rhinopharyngitis (p=0.000). Table 1 shows the distribution according the patients' age and the URTI diagnosis (Table 1) . Our results show, that the most affected age groups are from 1 to 6 years (p<0.5), with extremely close frequency in the first two groups and the most common diagnoses are rhinopharyngitis, tonsillopharyngitis and adenoiditis.
The comparison in the resistance patterns of 1998 with that of 2003, 2009 and of 2014 for different pathogens may be seen in Figure 2 and Figure 3 . Over the seventeen-year period, the regression of sensitivity to many antimicrobial drugs is detected. Overall antimicrobial susceptibility through the years statistically decreases from 1998 till 2014: for S. pneumoniae (p=0.010), S. pyogenes (p=0.000) and H. influenza (p=0.006), while the results for M. catarrhalis and S. aureus were not statistically significant with p=0.23 and p=0.11 respectively. Significant drop of susceptibility with p<0.05 from 1998 till 2014 towards particular antimicrobials for each pathogen was found for: penicillin, ampicillin, amoxicillin/clavulanic acid, azithromycin, tetracycline, sulfamethoxazole/trimethoprim and clindamycin for S. pneumoniae; azithromycin, tetracycline and clindamycin for S. pyogenes; penicillin, ampicillin, azithromycin and tetracycline for S. aureus; ampicillin, cefuroxime and tetracycline for H. influenzae; ampicillin, cephalexin and cefuroxime for M. catarrhalis.
DISCUSSION
The most widespread bacterial agents causing rhinosinusitis and ethmoiditis were S. pneumoniae and Staphylococcus aureus, followed rarely by H. influenzae and M. catarrhalis, while isolates in the majority of cases involved various combinations (Figure 1 ). From the results it is noteworthy that in contrast to the infectious process of some other body systems, the URTI, particularly rhinosinusitis, ethmoiditis, rhinopharyngitis and adenoiditis most often (in more than 70% of cases) were with polymicrobial etiology. Similar results have also been reported in our earlier studies as well as other authors (3, 4, 13, 14) .
The explanation may involve the fact that Gram-positive cocci form the most frequent type of nasal mucous coloniza- (Figure 1) . A little known fact is that the most common microbial combination of causative agents, actually are exactly those two microorganisms in association, not only for epiglottitis but also for other URTI as adenoiditis and rhinopharyngitis in children, that have been confirmed by other authors through the last years (14) .
Selective pressure from the common and not always well grounded use of macrolides in childhood leads to fast expansion of streptococcal strains with limited or absent susceptibility towards these antibiotics, which could lead to serious complications and sequels after infections caused by them (16) (17) (18) (19) (20) . Confirmed data for appearance of new more virulent strains of М. сatarrhalis with obligatory production of ß-lactamase during the last years have been published even in Bulgaria (8, 12) . Often mucous adhesion and pathogenic activity of one microorganism is enhanced in a presence of other species. This happens especially in cases with bacterial biofilm formation, where bacterial metabolism is amplified and thus the host immune defense system is more hampered by these more virulent bacterial species (2, 10) . In such cases the infection process, from upper respiratory tract mucus, propagates outside the initial localization and leads to complications such as middle ear infections or pneumonia, in some cases even it can lead to bacteremia or infections of central nervous system (2, 18, (20) (21) (22) .
Rhinopharyngitis and tonsillopharyngitis are predominantly in the age when the child is enrolled in kindergarten. While the first ones are mainly diagnosed for the younger children, tonsilopharyngitis are evenly distributed throughout the ages. Our data are supported by previous studies and could easily be explained by inefficiency of the local mucous defense in upper airways (1) (2) (3) 22, 23) . After the 6 th year of age, infections gradually decrease due to the sophistication of the immune system, and to the developing of adaptive immunity after initial contact with respiratory pathogens.
The basic mechanism leading to problematic resistance of staphylococci, moraxellae and haemophili towards ß-lactams is the production of enzymes that destruct the active center of the antimicrobial agent (ß-lactam ring). In the year 2014 100% of all samples of outpatient cases with M. сatarrhalis and almost 90% from S. аureus, produce β-lactamase, which makes them resistant to aminopenicillins without inhibitor, and moraxellae are resistant also to all first generation cephalosporins (Figure 2c-3b) . So far β-lactamase from M. catarrhalis, H. influenzae and S. aureus could be suppressed by the well-known inhibitors as sulbactam and clavulonic acid, but recently there were some reports for a broader spectrum of β-lactamase activity (5, 7, 16) .
High frequency of production of extracellular β-lactamase is accounted as an indirect virulence factor (12, 19) . Whether any of these microorganisms is an independent etiologic agent or is isolated with other susceptible bacteria as co-infection, most commonly streptococci, due to the actions of these extracellular enzymes, the effect of penicillin or cephalosporin in the treatment is suppressed. This prevents the eradication of the main causative agents that are sensitive to ß-lactam antibiotic and causes complications or development of chronic recurrent respiratory infection (10, 13) . The second more rare mechanism (the change of the penicillin-binding proteins) is the reason for resistance towards ß-lactams in near 20% of Bulgarian isolates S. рneumoniae and S. aureus (Figure 2a-c) . The latter has a strong negative effect on the actions of all penicillins and cephalosporins similar to the other countries in Europe and USA (7, 12, 15, 16) . First reports for macrolide-resistant S. рyogenes are published in the nineties in the end of the 20 th century (19) . Till 2003 we haven't isolated any resistant to macrolides S. рyogenes (Figure 2b) . In analyzing the results in our study it was noted that the first strains with lower susceptibility towards macrolides were detected in the year 2004 -in the year 2014 almost 23% of isolated in Bulgaria strains of S. pyogenes are with lower susceptibility towards the macrolides. Our results are similar to the results of multicenter study in Spain for an earlier period (2006) (2007) (16) . About 25% of S. pyogenes strains from macrolide resistant ones also express lower susceptibility towards lincosamides. Even higher macrolide-lincosamide resistance (over 30%) is noted in 2014 in the S. рneumoniae and S. aureus strains, as it is presented in Figure 2 . After the introducing of the new macrolides, suitable for respiratory infection therapy in childhood and their uncontrolled use for 10 years, now more than 1/3 from isolates are resistant to macrolides mainly due to prevail of the induced mechanism of resistance to lincosamides. In recent years similar alarming data have been reported in many other European and non-European countries (6, 7, 9, 16, 17, 19, 24) . This fast growing resistance Balkan Med J, Vol. 33, No. 6, 2016 due to the change of the action target in the last ten years has become a serious problem for therapy, particularly in combination with a change in penicillin-binding proteins because they are major classes of antimicrobial agents for the treatment of respiratory infections in children, and nowadays there has been reports for failures in the treatment of serious infections caused by multidrug-resistant strains (6, 9, 15, 19, 20) .
In conclusion, as the most common URTI pathogens, isolated mainly in polymicrobial associations, S. рneumoniae, H. influenzae, M. catarrhalis and S. aureus were identified; for tonsillopharyngitis, the predominant microorganism was S. pyogenes. URTI were most common in children of pre-school age. The most common resistance observed was to ß-lactams, due to the production of β-lactamase. Previously, this resistance could be bypassed by administereing amino-penicillin combined with a β-lactamase inhibitor, but this could be ineffective in the future. The most dynamically developing resistance in the last years has been that against macrolides in staphylococci and streptococci. This resistance often can be found crossed with low susceptibility towards other antimicrobial agents, mainly lincosamides. A combination of different resistance mechanisms in polyresistant strains has become more frequent in recent years and is extremely dangerous. The etiology of respiratory infections and the susceptibility to causative agents is changing and should be periodically monitored for correct antimicrobial policy and an accurate prognosis based on empirical therapy. Ethics Committee Approval: Ethics committee approval for this study was received from the ethics committee of Medical University of Sofia School of Medicine.
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